Moneycontrol PRO
Open App
you are here: HomeNewsIndia

Coronavirus Update | India's active COVID-19 case count drops to 64,667

The death toll climbed to 5,27,874 with 45 new fatalities which includes 10 deaths reconciled by Kerala, the data updated at 8 am stated.

August 31, 2022 / 10:18 AM IST
Representative image (REUTERS/Danish Siddiqui)

Representative image (REUTERS/Danish Siddiqui)

With 7,231 new infections being reported in a day, India's Covid-19 tally rose to 4,44,28,393, while the number of active cases came down to 64,667, according to the Union Health Ministry data updated on Wednesday.

The death toll climbed to 5,27,874 with 45 new fatalities which includes 10 deaths reconciled by Kerala, the data updated at 8 am stated.

The active cases comprise 0.15 per cent of the total infections, while the national Covid-19 recovery rate has increased to 98.67 per cent, the ministry said.

A drop of 1,065 cases has been recorded in the active Covid-19 case count in a span of 24 hours.

The daily positivity rate was recorded at 2.05 per cent. The weekly positivity rate was recorded at 2.55 per cent, according to the health ministry.


COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more

The number of people who have recuperated from the disease surged to 4,38,35,852, while the case fatality rate was recorded at 1.19 per cent.

According to the ministry, 212.39 crore doses of Covid vaccine have been administered in the country so far under the nationwide vaccination drive.

India's COVID-19 tally had crossed the 20-lakh mark on August 7, 2020; 30 lakh on August 23; 40 lakh on September 5 and 50 lakh on September 16. It went past 60 lakh on September 28; 70 lakh on October 11, crossed 80 lakh on October 29; 90 lakh on November 20 and surpassed one crore on December 19.

India crossed the grim milestone of two crore coronavirus cases on May 4, three crore on June 23 last year and four crore on January 25 this year.

(With inputs from PTI)
Moneycontrol News
first published: Aug 31, 2022 10:18 am
ISO 27001 - BSI Assurance Mark